Coronary artery calcium score: we know where we are but not where we may be

Author:

Mattesi GiuliaORCID,Savo Maria Teresa,De Amicis Morena,Amato Filippo,Cozza Elena,Corradin SimoneORCID,Da Pozzo StefanoORCID,Previtero MarcoORCID,Bariani RiccardoORCID,De Conti Giorgio,Rigato Ilaria,Pergola ValeriaORCID,Motta Raffaella

Abstract

Cardiac computed tomography angiography (CCTA) has emerged as a cost-effective and time-saving technique for excluding coronary artery disease. One valuable tool obtained by CCTA is the coronary artery calcium (CAC) score. The use of CAC scoring has shown promise in risk assessment and stratification of cardiovascular disease. CAC scores can be complemented by plaque analysis to assess vulnerable plaque characteristics and further refine risk assessment. This paper aims to provide a comprehensive understanding of the value of the CAC as a prognostic tool and its implications for patient risk assessment, treatment strategies and outcomes. CAC scoring has demonstrated superior ability in stratifying patients, especially asymptomatic individuals, compared to traditional risk factors and scoring systems. The main evidence suggests that individuals with a CAC score of 0 had a good long-term prognosis, while elevated CAC score is associated with increased cardiovascular risk. Finally, the clinical power of CAC scoring and the develop of new models for risk stratification could be enhanced by machine learning algorithms.

Publisher

PAGEPress Publications

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine

Reference61 articles.

1. Lloyd-Jones D, Adams RJ, Brown TM et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010 Feb 23;121(7):948-54. doi: 10.1161/CIRCULATIONAHA.109.192666. Erratum in: Circulation. 2010;121(12):e259. PMID: 20177011.

2. Agatston, AS, Janowitz, WR. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358(13):1336-1345.

3. Vahanian A, Beyersdorf F, Praz F, Milojevic M, et al; ESC/EACTS Scientific Document Group. Linee guida ESC/EACTS 2021 per il trattamento delle valvulopatie elaborate dalla Task Force per il trattamento delle valvulopatie della Società Europea di Cardiologia (ESC) e dell’Associazione Europea di Chirurgia Cardio-Toracica (EACTS) [2021 ESC/EACTS Guidelines for the management of valvular heart disease]. G Ital Cardiol (Rome). 2022 May;23(5 Suppl 1):e1-e75. Italian. doi: 10.1714/3787.37722. PMID: 35708463..

4. Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019 Nov;290:140-205. doi: 10.1016/j.atherosclerosis.2019.08.014. Epub 2019 Aug 31. Erratum in: Atherosclerosis. 2020;292:160-162. Erratum in: Atherosclerosis. 2020 Feb;294:80-82. PMID: 31591002.

5. Agatston AS, Janowitz WR, Hildner FJ et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827-32. doi: 10.1016/0735-1097(90)90282-t. PMID: 2407762.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3